Overview Dividends

(CG) Carlyle - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14316J1088

Private Equity, Real Assets, Credit, Infrastructure, Venture

CG EPS (Earnings per Share)

EPS Growth (3Y CAGR): -1.83%
EPS Trend (3Y Correlation): 41.5%

CG Revenue

Revenue Growth (3Y CAGR): 14.32%
Revenue Trend (3Y Correlation): 64.3%

Description: CG Carlyle October 16, 2025

The Carlyle Group Inc. (NASDAQ: CG) is a global alternative-asset manager that deploys capital through both direct investments and fund-of-fund structures, targeting a broad spectrum of strategies from leveraged buyouts and distressed credit to venture-stage growth and structured finance.

Its operations are organized into four core segments-Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions-allowing it to invest across more than 30 industries, including industrial manufacturing, aerospace & defense, fintech, renewable energy, and consumer retail. This diversification lets Carlyle capture value from macro-driven trends such as infrastructure spending, ESG-focused capital flows, and the ongoing digital transformation of traditional sectors.

As of the most recent filing, Carlyle reported approximately $426 billion in assets under management, generating $5.2 billion of revenue in 2023 with a net income margin of roughly 12 %, while fee-related earnings grew 8 % year-over-year, reflecting strong fundraising momentum and higher fee-related earnings from its expanding private-equity and real-asset platforms. For investors seeking deeper quantitative analysis, a look-up on ValueRay can provide granular, up-to-date performance metrics and scenario modeling tools.

CG Stock Overview

Market Cap in USD	19,286m
Sub-Industry	Asset Management & Custody Banks
IPO / Inception	2012-05-03

CG Stock Ratings

Growth Rating	61.5%
Fundamental	59.4%
Dividend Rating	65.2%
Return 12m vs S&P 500	-9.80%
Analyst Rating	3.56 of 5

CG Dividends

Dividend Yield 12m	2.67%
Yield on Cost 5y	5.89%
Annual Growth 5y	8.78%
Payout Consistency	91.2%
Payout Ratio	35.6%

CG Growth Ratios

Growth Correlation 3m	-73.7%
Growth Correlation 12m	50.1%
Growth Correlation 5y	48.3%
CAGR 5y	24.82%
CAGR/Max DD 3y (Calmar Ratio)	0.64
CAGR/Mean DD 3y (Pain Ratio)	2.25
Sharpe Ratio 12m	0.89
Alpha	-22.31
Beta	1.990
Volatility	39.71%
Current Volume	3065k
Average Volume 20d	2846.4k
Stop Loss	50.4 (-3.9%)
Signal	-0.27

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (1.26b TTM) > 0 and > 6% of Revenue (6% = 398.1m TTM)

FCFTA 0.04 (>2.0%) and ΔFCFTA 4.49pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -66.53% (prev -60.44%; Δ -6.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.04 (>3.0%) and CFO 969.3m <= Net Income 1.26b (YES >=105%, WARN >=100%)

Net Debt (8.97b) to EBITDA (1.85b) ratio: 4.84 <= 3.0 (WARN <= 3.5)

Current Ratio 0.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (367.0m) change vs 12m ago 0.03% (target <= -2.0% for YES)

Gross Margin 83.17% (prev 83.97%; Δ -0.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 28.02% (prev 17.49%; Δ 10.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.42 (EBITDA TTM 1.85b / Interest Expense TTM 688.1m) >= 6 (WARN >= 3)

Altman Z'' -0.32

(A) -0.18 = (Total Current Assets 2.07b - Total Current Liabilities 6.49b) / Total Assets 25.07b

(B) 0.08 = Retained Earnings (Balance) 1.95b / Total Assets 25.07b

(D) 0.11 = Book Value of Equity 1.95b / Total Liabilities 18.35b

Total Rating: -0.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 59.36

1. Piotroski 3.0pt = -2.0

2. FCF Yield 3.15% = 1.57

3. FCF Margin 13.40% = 3.35

4. Debt/Equity 1.59 = 1.35

5. Debt/Ebitda 4.84 = -2.50

6. ROIC - WACC (= -0.88)% = -1.10

7. RoE 21.43% = 1.79

8. Rev. Trend 64.32% = 4.82

9. EPS Trend 41.54% = 2.08

What is the price of CG shares?

As of November 08, 2025, the stock is trading at USD 52.43 with a total of 3,064,964 shares traded.
Over the past week, the price has changed by -1.67%, over one month by -14.90%, over three months by -14.38% and over the past year by +2.85%.

Is Carlyle a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Carlyle is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 59.36 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CG is around 49.15 USD . This means that CG is currently overvalued and has a potential downside of -6.26%.

Is CG a buy, sell or hold?

Carlyle has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold CG.

Strong Buy: 4
Buy: 3
Hold: 10
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the CG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	67.8	29.2%
Analysts Target Price	67.8	29.2%
ValueRay Target Price	55.1	5.1%

CG Fundamental Data Overview November 04, 2025

Market Cap USD = 19.29b (19.29b USD * 1.0 USD.USD)
P/E Trailing = 15.5906
P/E Forward = 12.4378
P/S = 6.0113
P/B = 3.8093
P/EG = 0.9788
Beta = 1.99
Revenue TTM = 6.64b USD
EBIT TTM = 1.67b USD
EBITDA TTM = 1.85b USD
Long Term Debt = unknown (none)
Short Term Debt = 458.2m USD (from shortTermDebt, last fiscal year)
Debt = 10.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.97b USD (from netDebt column, last quarter)
Enterprise Value = 28.25b USD (19.29b + Debt 10.71b - CCE 1.74b)
Interest Coverage Ratio = 2.42 (Ebit TTM 1.67b / Interest Expense TTM 688.1m)
FCF Yield = 3.15% (FCF TTM 889.3m / Enterprise Value 28.25b)
FCF Margin = 13.40% (FCF TTM 889.3m / Revenue TTM 6.64b)
Net Margin = 18.93% (Net Income TTM 1.26b / Revenue TTM 6.64b)
Gross Margin = 83.17% ((Revenue TTM 6.64b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 60.12% (prev 85.48%)
Tobins Q-Ratio = 1.13 (Enterprise Value 28.25b / Total Assets 25.07b)
Interest Expense / Debt = 1.86% (Interest Expense 198.8m / Debt 10.71b)
Taxrate = 25.53% (112.5m / 440.6m)
NOPAT = 1.24b (EBIT 1.67b * (1 - 25.53%))
Current Ratio = 0.32 (Total Current Assets 2.07b / Total Current Liabilities 6.49b)
Debt / Equity = 1.59 (Debt 10.71b / totalStockholderEquity, last quarter 6.72b)
Debt / EBITDA = 4.84 (Net Debt 8.97b / EBITDA 1.85b)
Debt / FCF = 10.08 (Net Debt 8.97b / FCF TTM 889.3m)
Total Stockholder Equity = 5.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.01% (Net Income 1.26b / Total Assets 25.07b)
RoE = 21.43% (Net Income TTM 1.26b / Total Stockholder Equity 5.86b)
RoCE = 8.96% (EBIT 1.67b / Capital Employed (Total Assets 25.07b - Current Liab 6.49b))
RoIC = 8.20% (NOPAT 1.24b / Invested Capital 15.13b)
WACC = 9.08% (E(19.29b)/V(29.99b) * Re(13.35%) + D(10.71b)/V(29.99b) * Rd(1.86%) * (1-Tc(0.26)))
Discount Rate = 13.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.86%
[DCF Debug] Terminal Value 50.67% ; FCFE base≈889.3m ; Y1≈583.9m ; Y5≈267.0m
Fair Price DCF = 7.75 (DCF Value 2.80b / Shares Outstanding 361.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 41.54 | EPS CAGR: -1.83% | SUE: -0.73 | # QB: 0
Revenue Correlation: 64.32 | Revenue CAGR: 14.32% | SUE: 0.76 | # QB: 0

Additional Sources for CG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle